Collaboration - December 20, 2019
Season’s Greetings from Nordic Life Science
We would like to thank our readers, subscribers and collaboration partners for a fruitful, eventful and fun 2019, and we wish you all a most wonderful holiday season! Nordic Life Science will be back on January 7th 2020 to provide you with the latest news from our exciting life science industry! Until then, here are […]
Collaboration - December 19, 2019
BioArctic enters new collaboration with Eisai
BioArctic has announced the initiation of a research collaboration with Eisai aimed at further studying the profile of the investigational drug candidate BAN2401. The research collaboration with Eisai is in addition to the existing development and commercialization agreement for BAN2401. This new research collaboration is intended to further characterize the binding profile of BAN2401. “We […]
Collaboration - December 3, 2019
Elekta collaborates with ViewRay
Elekta has signed a non-binding Memorandum of Understanding with ViewRay to advance the knowledge and application of MR-guided radiation therapy. In connection with the collaboration, Elekta has committed to make an investment in ViewRay representing approximately 9.9 percent of the shares of ViewRay’s common stock, outstanding after the public offering, to be announced by ViewRay, […]
Collaboration - November 27, 2019
Novo Nordisk and UNICEF announce new partnership
Novo Nordisk and UNICEF have announced a new partnership to help prevent childhood overweight and obesity worldwide with an initial focus on interventions in Latin America and the Caribbean. Under this partnership, the United Nations children’s agency and the global healthcare company will combine efforts to enhance knowledge and awareness on how to prevent overweight […]
Clinical Trials - November 12, 2019
Follicum collaborates with proDERM
Follicum has announced that the company has signed a collaboration agreement with proDERM for conducting the new clinical trial with a cream-like formulation of FOL-005 to be tested on alopecia patients (patients with hair loss). The company expects to be ready for starting the clinical trial shortly after the turn of the year. Preparations for […]
Collaboration - October 16, 2019
AroCell collaborates with Tampere University Hospital
The purpose of the collaboration is to evaluate AroCell’s TK 210 ELISA for Thymidine Kinase 1 (TK1) as a prognostic biomarker in subjects with prostate cancer. In the study TK1 protein levels will be assayed in serum samples collected from subjects with newly diagnosed prostate cancer and compared with the extent and speed of disease […]
